Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats

• Published in: The European journal of neuroscience 2024-05, Vol.59 (10), p.2436-2449
• Main Authors: Hersey, Melinda, Mereu, Maddalena, Jones, Claire S., Bartole, Mattingly K., Chen, Andy Y., Cao, Jianjing, Hiranita, Takato, Chun, Lauren E., Lopez, Jessica P., Katz, Jonathan L., Newman, Amy Hauck, Tanda, Gianluigi
• Format: Article
• Language: English
• Subjects: addiction; Animals; Benzhydryl Compounds - pharmacology; Cocaine; Cocaine - pharmacology; Dopamine; dopamine (DA); Dopamine - metabolism; Dopamine Plasma Membrane Transport Proteins - antagonists & inhibitors; Dopamine transporter; dopamine transporter (DAT); Dopamine Uptake Inhibitors - pharmacology; Male; Microdialysis; Microdialysis - methods; Modafinil; Modafinil - pharmacology; Nucleus accumbens; Nucleus Accumbens - drug effects; Nucleus Accumbens - metabolism; Piperidines - pharmacology; Rats; Rats, Sprague-Dawley; Receptors, sigma - antagonists & inhibitors; rimcazole; sigma receptor; Sigma receptors; substance use disorder
• ISSN: 0953-816X; 1460-9568; 1460-9568
• DOI: 10.1111/ejn.16293

Psychostimulant use disorders (PSUD) are prevalent; however, no FDA‐approved medications have been made available for treatment. Previous studies have shown that dual inhibitors of the dopamine transporter (DAT) and sigma receptors significantly reduce the behavioral/reinforcing effects of cocaine, which have been associated with stimulation of extracellular dopamine (DA) levels resulting from DAT inhibition. Here, we employ microdialysis and fast scan cyclic voltammetry (FSCV) procedures to investigate the effects of dual inhibitors of DAT and sigma receptors in combination with cocaine on nucleus accumbens shell (NAS) DA dynamics in naïve male Sprague Dawley rats. In microdialysis studies, administration of rimcazole (3, 10 mg/kg; i.p.) or its structural analog SH 3‐24 (1, 3 mg/kg; i.p.), compounds that are dual inhibitors of DAT and sigma receptors, significantly reduced NAS DA efflux stimulated by increasing doses of cocaine (0.1, 0.3, 1.0 mg/kg; i.v.). Using the same experimental conditions, in FSCV tests, we show that rimcazole pretreatments attenuated cocaine‐induced stimulation of evoked NAS DA release but produced no additional effect on DA clearance rate. Under the same conditions, JJC8‐091, a modafinil analog and dual inhibitor of DAT and sigma receptors, similarly attenuated cocaine‐induced stimulation of evoked NAS DA release but produced no additional effect on DA clearance rate. Our results provide the neurochemical groundwork towards understanding actions of dual inhibitors of DAT and sigma receptors on DA dynamics that likely mediate the behavioral effects of psychostimulants like cocaine. Studies using microdialysis and fast scan cyclic voltammetry suggest that dual inhibitors of DAT and sigma receptors reduce the stimulation of dopamine transmission produced by cocaine in a brain area that plays a significant role in the actions of cocaine as a reinforcer of behavior and consequently its addictive properties. Thus, compounds that inhibits both DAT and sigma receptors show promise as therapeutic options for psychostimulant use disorder.